SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

Exclusion Criteria

• •1. Patients who are recipients of multiple organ transplants, including more than one kidney, kidney and pancreas, or previous transplant with any organ other than kidney.
• •2. Patients at high immunological risk of graft loss, indicated by peak PRA \>50% or loss of a previous renal allograft within the first 6 months of transplantation due to acute rejection.
• •3. Patients who have received an investigational drug within 4 weeks prior to the screening visit.
• •4. Presence of any severe allergy or hypersensitivity to drugs similar to everolimus (e.g. antibiotics such as Clindamycin)